“特朗普药房”上线！特朗普：这些药价将大幅下降，最高达600%

Core Viewpoint - The Trump administration announced the launch of a new website called "TrumpRx" aimed at allowing Americans to purchase prescription drugs directly from manufacturers at significantly discounted prices, bypassing traditional insurance systems and intermediaries [2][3]. Group 1: Pricing Strategy - TrumpRx will enable consumers to buy specific drugs at government-negotiated discount prices, potentially reducing drug prices by as much as 300% to 600% or more in some cases [3][4]. - The initiative is based on agreements with over a dozen pharmaceutical companies, including Amgen, Eli Lilly, Gilead, and Pfizer, under a "most favored nation" pricing policy [4][5]. Group 2: Pharmaceutical Company Agreements - Pfizer was the first company to announce an agreement with the government, stating that patients could purchase its drugs at an average discount of 50%, covering most primary care and some specialty brand medications [4]. - Following Pfizer, the Trump administration secured similar agreements with several other pharmaceutical companies in late 2022 [5]. Group 3: Political and Expert Reactions - Some Democratic lawmakers and healthcare policy experts expressed skepticism about the effectiveness of TrumpRx, questioning whether it would provide substantial savings for consumers and highlighting the existing discounts available through other means [6][8]. - Concerns were raised regarding the legality and safety of expedited FDA approvals for participating drug companies, suggesting that rushed processes could be dangerous [7].